Billebeau, Aurore
,
Fain, Olivier
Launay, David
Boccon-Gibod, Isabelle
Bouillet, Laurence
Gobert, Delphine
Plu-Bureau, Geneviève
Gompel, Anne http://orcid.org/0000-0001-9614-6968
Article History
Received: 1 May 2020
Accepted: 26 October 2020
First Online: 31 October 2020
Compliance with Ethical Standards
:
: AB: no conflict of interest, OF: Consultant arrangements for Shire/Takeda and Behring, travel and accommodation to a Congress from GSK, honorarium for a talk from Sanofi, DL: consultant arrangements, research grant and travel and accommodation from Actelion, GSK, Octapharma, Pfizer, and Shire/Takeda. LB: Consultant arrangements, research grant and travel and accommodation from Shire/Takeda, CSL Behring, Pharming, GSK, Novartis, Sanofi. I B-G: Consultant arrangements, research grant, travel and accommodation from Shire/Takeda, CSL Behring, Pharming, Biocryst, Novartis DG: Consultant arrangements for Shire/Takeda honorarium for talks for Shire/Takeda, travel and accommodation from Shire/Takeda et Pharming. G.P-B: no conflict of interest. AG: member of an advisory board for Mithra (Estetrol).